FDA Clears Automated Insulin Dosing App for Patients With Type 1 Diabetes
The prescription-only device works with integrated continuous glucose monitors and alternate controller enabled pumps.
Diagnosis & Disease Information
Brenzavvy Approved for Adults With Type 2 Diabetes
The approval was based on data from a clinical program that included 23 clinical trials enrolling more than 5000 adults with type 2 diabetes mellitus.
Rybelsus Now First-Line Option for Type 2 Diabetes Following Label Update
Rybelsus is a glucagon-like peptide receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Nonsteroidal MRAs Reduce Kidney, Cardiovascular Risks
The systematic review and meta-analysis included a broad range of patients with and without chronic kidney disease.
Layered Approach Recommended for Patients With Diabetes, CKD
Layered approach involves initially combining lifestyle interventions, self-management, and first-line pharmacotherapy
Best Diets According to the Experts: 2023 Rankings Revealed
A 33 person panel of physicians, registered dietitian nutritionists, and nutritional epidemiologists assessed 24 diets to come up with the final results.
Guidelines Updated for Reducing Hypoglycemia Risk in Diabetes
Strong recommendations include use of glucagon preparations that do not need reconstitution, real-time CGM for those receiving multiple daily injections
Glycemic Control Stagnant in US From 1988 to 2020
Mexican American adults receiving insulin less likely than non-Hispanic Whites to achieve glycemic control
Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
Reduced risk seen for total knee replacement and total hip replacement with metformin use
Resistant Hypertension Effectively Treated With Novel Drug
Blocking the endothelin pathway could represent a new mode of action to lower blood pressure in resistant hypertension, according to investigators.
